Olympus Corporation (OLYMY)

Market Cap	13.06B
Revenue (ttm)	6.66B
Net Income (ttm)	787.02M
Shares Out	n/a
EPS (ttm)	0.69
PE Ratio	16.59
Forward PE	n/a
Dividend	0.13 (1.14%)
Ex-Dividend Date	Mar 28, 2025

Volume	n/a
Average Volume	83,625
Open	11.69
Previous Close	11.85
Day's Range	11.69 - 11.69
52-Week Range	11.09 - 19.69
Beta	0.52
RSI	33.70
Earnings Date	Aug 8, 2025

About Olympus

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1919
• Employees: 29,297
• Stock Exchange: OTCMKTS
• Ticker Symbol: OLYMY

Financial Performance

In 2024, Olympus's revenue was 997.33 billion, an increase of 6.53% compared to the previous year's 936.21 billion. Earnings were 117.86 billion, a decrease of -51.41%.

Financial numbers in JPY